Concepedia

Carl Gommoll

CG

Statistics

Publications

29

Citations

1.2K

H-Index

19

Active since

1997

Affiliations

Forest Research Institute(Current)

Allergan (United States)

Prescott College

Institute for Advanced Medical Research

GTx (United States)

Carl Gommoll is an author at Forest Research Institute specializing in psychopharmacology, antidepressant pharmacotherapy, and antidepressant pharmacology.

Publications per year

1997–2018

29

Publications

29

Safety and Tolerability of Levomilnacipran ER in Major Depressive Disorder: Results from an Open-Label, 48-Week Extension Study

Rajnish Mago, Giovanna Forero, William M. Greenberg et al. · Clinical Drug Investigation · 2013 · 195 citations · Full text

, , +17

Regulation of granulocyte colony-stimulating factor gene expression by interleukin-17

Xiao-Yan Cai, Carl Gommoll, Luminita Justice et al. · Immunology Letters · 1998 · 101 citations

, , +12

Double-Blind Comparison of Escitalopram and Duloxetine in??the??Acute Treatment of Major??Depressive Disorder

Arif Khan, Anjana Bose, George S. Alexopoulos et al. · Clinical Drug Investigation · 2007 · 93 citations

, , +15

A Phase III, Double-Blind, Placebo-Controlled, Flexible-Dose Study of Levomilnacipran Extended-Release in Patients With Major Depressive Disorder

Angelo Sambunaris, Anjana Bose, Carl Gommoll et al. · Journal of Clinical Psychopharmacology · 2013 · 90 citations · Full text

, , +17

Efficacy and Safety of Levomilnacipran Sustained Release 40 mg, 80 mg, or 120 mg in Major Depressive Disorder

Gregory M. Asnis, Anjana Bose, Carl Gommoll et al. · The Journal of Clinical Psychiatry · 2013 · 83 citations · Full text

, , +17

1–5 of 29